Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5191451
Max Phase: Preclinical
Molecular Formula: C18H14F2N2O3
Molecular Weight: 344.32
Associated Items:
ID: ALA5191451
Max Phase: Preclinical
Molecular Formula: C18H14F2N2O3
Molecular Weight: 344.32
Associated Items:
Canonical SMILES: O=C(NCCc1ccc2c(c1)OCO2)c1cc2c(F)cc(F)cc2[nH]1
Standard InChI: InChI=1S/C18H14F2N2O3/c19-11-6-13(20)12-8-15(22-14(12)7-11)18(23)21-4-3-10-1-2-16-17(5-10)25-9-24-16/h1-2,5-8,22H,3-4,9H2,(H,21,23)
Standard InChI Key: GJWCCGFDLGWEPL-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 344.32 | Molecular Weight (Monoisotopic): 344.0972 | AlogP: 3.15 | #Rotatable Bonds: 4 |
Polar Surface Area: 63.35 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.58 | CX Basic pKa: | CX LogP: 2.99 | CX LogD: 2.99 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.76 | Np Likeness Score: -0.90 |
1. Alsayed SSR, Suri A, Bailey AW, Lane S, Werry EL, Huang CC, Yu LF, Kassiou M, Sredni ST, Gunosewoyo H.. (2021) Synthesis and antitumour evaluation of indole-2-carboxamides against paediatric brain cancer cells., 12 (11.0): [PMID:34825187] [10.1039/D1MD00065A] |
Source(1):